Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3856)
All Articles published online
|
May 21, 2012 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang YL, Zhu ZJ, Teng DH, Yao Z, Gao W, Shen ZY. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation. World J Gastroenterol 2012; 18(19): 2408-2414 [PMID: 22654434 DOI: 10.3748/wjg.v18.i19.2408] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v18/i19/2408.htm |
| Number | Citing Articles |
| 1 |
Min Yao, Li Wang, Miao Fang, Wenjie Zheng, Zhizhen Dong, Dengfu Yao. Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma. BioScience Trends 2016; 10(5): 337 doi: 10.5582/bst.2016.01176
|
| 2 |
Wenpeng Li, Linjie Guo, Purva Rathi, Ekaterina Marinova, Xiuhua Gao, Meng-Feng Wu, Hao Liu, Gianpietro Dotti, Stephen Gottschalk, Leonid S. Metelitsa, Andras Heczey. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity. Human Gene Therapy 2017; 28(5): 437 doi: 10.1089/hum.2016.025
|
| 3 |
Miho Kawaida, Ken Yamazaki, Hanako Tsujikawa, Mariko Fukuma, Yuta Abe, Minoru Kitago, Masahiro Shinoda, Yuko Kitagawa, Michiie Sakamoto. Diffuse and canalicular patterns of glypican‐3 expression reflect malignancy of hepatocellular carcinoma. Pathology International 2019; 69(3): 125 doi: 10.1111/pin.12767
|
| 4 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies. International Journal of Molecular Sciences 2022; 23(17): 10038 doi: 10.3390/ijms231710038
|
| 5 |
Song-Zhu Yang, Jian-Tao Wang, Wei-Wei Yu, Qing Liu, Yan-Fang Wu, Shu-Guang Chen. Downregulation of <italic>KIF1B</italic> mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. World Journal of Gastroenterology 2015; 21(27): 8418-8424 doi: 10.3748/wjg.v21.i27.8418
|
| 6 |
Yan Wang, Shengjie Jin, Qiqi Zhuang, Na Liu, Ruyi Chen, Sofia Abdulkadir Adam, Jie Jin, Jie Sun. Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy. MedComm 2023; 4(6) doi: 10.1002/mco2.422
|
| 7 |
Shuxia Liu, Minjie Wang, Cuiling Zheng, Qiaofeng Zhong, Yuankai Shi, Xiaohong Han. Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer. Clinical Biochemistry 2020; 79: 54 doi: 10.1016/j.clinbiochem.2020.02.009
|
| 8 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
| 9 |
Xiufeng Zheng, Xun Liu, Yanna Lei, Gang Wang, Ming Liu. Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.824208
|
| 10 |
A. Kornberg. Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/706945
|
| 11 |
Li Wang, Min Yao, Liu-Hong Pan, Qi Qian, Deng-Fu Yao. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2015; 14(4): 361 doi: 10.1016/S1499-3872(15)60396-4
|
| 12 |
Donglei Jiang, Yingshi Zhang, Yinuo Wang, Fu Xu, Jun Liang, Weining Wang. Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1012418
|
| 13 |
Xiangyan Xiao, Qiyuan Huang, Xiaocong Lin, Kashif Rafiq Zahid, Xueran Huang, Tiancai Liu, Tao Zeng. Current methods for the detection of glypican-3. Analytical Methods 2024; 16(2): 152 doi: 10.1039/D3AY01523H
|
| 14 |
Bita Moudi, Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb. Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma. VirusDisease 2019; 30(2): 193 doi: 10.1007/s13337-019-00517-6
|
| 15 |
Masatake Taniguchi, Shoichi Mizuno, Toshiaki Yoshikawa, Norihiro Fujinami, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda, Tetsuya Nakatsura. Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis. Cancer Science 2020; 111(8): 2747 doi: 10.1111/cas.14497
|
| 16 |
Zhijun Geng, Yunfei Zhang, Shutong Wang, Hui Li, Cheng Zhang, Shaohan Yin, Chuanmiao Xie, Yongming Dai. Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histopathology and Radiomics Features. Magnetic Resonance in Medical Sciences 2021; 20(3): 253 doi: 10.2463/mrms.mp.2020-0060
|
| 17 |
Y.-L. Wang, G. Li, Y.-X. Fu, H. Wang, Z.-Y. Shen. Blockade of OX40/OX40 Ligand to Decrease Cytokine messenger RNA Expression in Acute Renal Allograft Rejection In Vitro. Transplantation Proceedings 2013; 45(6): 2565 doi: 10.1016/j.transproceed.2013.03.038
|
| 18 |
Yasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike. Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(10): 3070 doi: 10.3390/ijms19103070
|
| 19 |
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C. Arquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
|
| 20 |
Joydeep Chakraborty, Eric Hilgenfeldt, Roniel Cabrera. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 175 doi: 10.1007/978-3-319-68082-8_10
|
| 21 |
Wei Chen, Hao Wang, Tong Li, Te Liu, Wenjing Yang, Anli Jin, Lin Ding, Chunyan Zhang, Baishen Pan, Wei Guo, Beili Wang. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01162-7
|
| 22 |
Marina Curado Valsechi, Ana Beatriz Bortolozo Oliveira, André Luis Giacometti Conceição, Bruna Stuqui, Natalia Maria Candido, Paola Jocelan Scarin Provazzi, Luiza Ferreira de Araújo, Wilson Araújo Silva, Marilia de Freitas Calmon, Paula Rahal. GPC3 reduces cell proliferation in renal carcinoma cell lines. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-631
|
| 23 |
Yukihiro Haruyama, Hiroaki Kataoka. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 275-283 doi: 10.3748/wjg.v22.i1.275
|
| 24 |
Xiao Cui, Zhao Li, Peng-Ji Gao, Jie Gao, Ji-Ye Zhu. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2015; 14(2): 157 doi: 10.1016/S1499-3872(15)60349-6
|
| 25 |
Sevcan ATAY. Hepatit-B virüs ilişkili hepatosellüler karsinomda tümöral glipikan 3 mRNA seviyesinin diagnostik ve prognostik biyobelirteç olabilme potansiyelinin entegratif transkriptomik meta-analiz ve biyoinformatik ile değerlendirilmesi. Ege Tıp Dergisi 2022; 61(2): 249 doi: 10.19161/etd.1127225
|
| 26 |
Jian Zhang, Manka Zhang, Huimin Ma, Xincheng Song, Lingling He, Xiaohui Ye, Xin Li. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma. Medicine 2018; 97(24): e11130 doi: 10.1097/MD.0000000000011130
|
| 27 |
|
| 28 |
Mihai Pomohaci, Mugur Grasu, Radu Dumitru, Mihai Toma, Ioana Lupescu. Liver Transplant in Patients with Hepatocarcinoma: Imaging Guidelines and Future Perspectives Using Artificial Intelligence. Diagnostics 2023; 13(9): 1663 doi: 10.3390/diagnostics13091663
|
| 29 |
Jinyu Hu, Zhiwei Gao. Data-based core genes screening for Hepatocellular Carcinoma. 2014 9th IEEE Conference on Industrial Electronics and Applications 2014; : 1102 doi: 10.1109/ICIEA.2014.6931330
|
| 30 |
Umberto Cillo, Tommaso Giuliani, Marina Polacco, Luz Maria Herrero Manley, Gino Crivellari, Alessandro Vitale. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World Journal of Gastroenterology 2016; 22(1): 232-252 doi: 10.3748/wjg.v22.i1.232
|
| 31 |
Jianfeng Zhao, Lijuan Lin, Yihua Luo, Qinghe Cai, Xiaojie Jiang, Changxi Liao, Huimin Wei. Optimization of GPC3-specific chimeric antigen receptor structure and its effect on killing hepatocellular carcinoma cells. Bioengineered 2021; 12(1): 3674 doi: 10.1080/21655979.2021.1950261
|
| 32 |
Huanhuan Chong, Yuda Gong, Yunfei Zhang, Yongming Dai, Ruofan Sheng, Mengsu Zeng. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence. Academic Radiology 2023; 30(1): 49 doi: 10.1016/j.acra.2022.04.006
|
| 33 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 65 doi: 10.1007/978-3-319-26956-6_3
|
| 34 |
Y.-L. Wang, G. Li, X.-F. Zou, X.-B. Chen, T. Liu, Z.-Y. Shen. Effect of Autologous Adipose-Derived Stem Cells in Renal Cold Ischemia and Reperfusion Injury. Transplantation Proceedings 2013; 45(9): 3198 doi: 10.1016/j.transproceed.2013.07.061
|
| 35 |
Wei-Kai Xiao, Chao-Ying Qi, Dong Chen, Shao-Qiang Li, Shun-Jun Fu, Bao-Gang Peng, Li-Jian Liang. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-104
|
| 36 |
Preithy Uthamalingam, Ashim Das, Arunanshu Behra, Naveen Kalra, Yogesh Chawla. Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers. Journal of Clinical and Experimental Hepatology 2018; 8(2): 173 doi: 10.1016/j.jceh.2017.09.005
|
| 37 |
YULIANG WANG, YINLONG WANG, HONG MU, TAO LIU, XIAOBO CHEN, ZHONGYANG SHEN. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells. Molecular Medicine Reports 2015; 11(5): 3361 doi: 10.3892/mmr.2015.3239
|
| 38 |
Jian-Yao Wang, Xiang-Kun Wang, Guang-Zhi Zhu, Xin Zhou, Jun Yao, Xiao-Peng Ma, Bin Wang, Tao Peng. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08104-z
|
| 39 |
Fubo Zhou, Wenting Shang, Xiaoling Yu, Jie Tian. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Medicinal Research Reviews 2018; 38(2): 741 doi: 10.1002/med.21455
|
| 40 |
Andrea Casadei-Gardini, Orsi Giulia, Caputo Francesco, Ercolani Giorgio. Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Review of Anticancer Therapy 2020; 20(1): 63 doi: 10.1080/14737140.2020.1712198
|
| 41 |
Yejoo Jeon, Haeryoung Kim, Eun Sun Jang, Sukho Hong, Jin Wook Kim, Yoo‐Seok Yoon, Jai Young Cho, Ho‐Seong Han, Sook‐Hyang Jeong. Expression profile and prognostic value of glypican‐3 in post‐operative South Korean hepatocellular carcinoma patients. APMIS 2016; 124(3): 208 doi: 10.1111/apm.12491
|
| 42 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_3-1
|